₨ NPR
Description
RESERT-25 is a selective serotonin reuptake inhibitor (SSRI) antidepressant containing Sertraline (25mg). It is primarily prescribed for depression, anxiety disorders, and OCD, with a lower starting dose ideal for gradual titration or sensitive patients.
Key Features:
✔ Low-dose initiation (minimizes early side effects)
✔ FDA-approved for multiple psychiatric conditions
✔ Once-daily dosing (typically in morning)
Mechanism of Action:
→ Potently blocks serotonin (5-HT) reuptake → increases synaptic serotonin levels
→ Mild effects on dopamine and norepinephrine
→ No significant anticholinergic effects (unlike TCAs)
Approved Uses:
-
Major Depressive Disorder (MDD)
-
Obsessive-Compulsive Disorder (OCD)
-
Panic Disorder
-
Social Anxiety Disorder
-
Post-Traumatic Stress Disorder (PTSD)
-
Premenstrual Dysphoric Disorder (PMDD)
Dosage & Administration:
- Initial dose: 25mg once daily (may increase to 50-200mg/day)
- Swallow whole with water (with/without food)
- Morning dosing preferred (unless causes drowsiness)
- Elderly: Start with 25mg (slower titration)
Side Effects:
Common (First 2 Weeks):
- Nausea
- Insomnia/drowsiness
- Dry mouth
- Diarrhea
Additional information
| form | Oral Tablets |
|---|
Reviews
There are no reviews yet.